How has Artiva Biotherapeutics, Inc.'s compensation and benefits changed year-over-year?

Artiva Biotherapeutics, Inc.'s compensation and benefits increased by 25.8% year-over-year, from $2.53M to $3.18M.

What is the long-term trend for Artiva Biotherapeutics, Inc.'s compensation and benefits?

Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s compensation and benefits has grown at a 36.8% compound annual growth rate (CAGR), from $4.05M to $7.57M.

Artiva Biotherapeutics, Inc. ARTV Compensation and benefits

Compensation and benefits at other companies

Immix Biopharma, Inc.IMMX

——

Nektar TherapeuticsNKTR

——

Avalo TherapeuticsAVTX

——

Viridian Therapeutics, Inc.VRDN

——

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s compensation and benefits?: Artiva Biotherapeutics, Inc. (ARTV) reported compensation and benefits of $3.18M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s compensation and benefits changed year-over-year?: Artiva Biotherapeutics, Inc.'s compensation and benefits increased by 25.8% year-over-year, from $2.53M to $3.18M.
What is the long-term trend for Artiva Biotherapeutics, Inc.'s compensation and benefits?: Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s compensation and benefits has grown at a 36.8% compound annual growth rate (CAGR), from $4.05M to $7.57M.